Credit Suisse’s Aurora Cannabis ACB Stock Holding History

Credit Suisse’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-303	Closed	-$33K	–	3931
2020 Q1	$33K	Buy	+303	New	+$54.1K	﹤0.01%	3929

Other funds holding ACB

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Credit Suisse's ACB Position: Q2 2023 in Review

Credit Suisse sold out of Aurora Cannabis (ACB) in Q2 2023, closing a stake of 35,223 shares — an estimated $246K sold.

Credit Suisse first reported a position in ACB in Q4 2018 and held it in 18 quarters. The position peaked at $22.4M in Q4 2018. 195 funds tracked by Wall St. Rank hold ACB as of Q2 2023.

Credit Suisse reported no remaining Aurora Cannabis position as of Q2 2023 after selling out during the quarter.
Credit Suisse sold 35,223 Aurora Cannabis shares in Q2 2023, an estimated $246K.
Credit Suisse first reported a position in Aurora Cannabis in Q4 2018 and held it in 18 quarters.
Credit Suisse's Aurora Cannabis position peaked at $22.4M in Q4 2018.
195 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2023.

Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.